News & Articles

Connecting the scientific community with two new online content-packed events

Nirsevimab is the first potential passive immunisation for infants to demonstrate sustained protection across the entire RSV season with a single dose

In two clinical trials, Evrysdi improved motor function in people living with SMA over a broad spectrum of ages and levels of disease severity, including Types 1, 2, and 3 SMA

The high-throughput system enables laboratories to double or even triple their testing capacity

Join us on Tuesday, August 11, to learn about a novel serological platform used for COVID-19 testing

Join us on Monday, August 17, to discover solutions for your laboratory's SARS-CoV-2 testing

BLENREP is the fifth major medicine approval for GSK in 2020

Exclusive interviews, new methods, free downloads, and much more to help you advance your work

Watch this on-demand webinar to discover how pancreatic cancer-derived organoids can be used as a predictive tool for personalized medicine

87 percent of patients in ZUMA-2 pivotal trial responded to single infusion of Tecartus

Informatics tools help scientists access, aggregate and analyze drug compound and clinical trial data

The study is the first global, randomized, double-blind, placebo-controlled phase III trial investigating Actemra/RoActemra in this setting

Saphyr’s extremely sensitive structural variation detection technology will be used to analyze samples from COVID patients from dozens of clinical sites throughout North America and Europe

When patients report muscle-related symptoms, blood tests can provide reassurance about continuing statin therapy to help prevent heart attacks and strokes

The ViroKey™ SARS-CoV-2 RT-PCR Test v2.0 is a probe-based reverse transcription PCR test

The NeuroSphere Digital Care offers flexible virtual care options as the COVID-19 global pandemic impacts how healthcare is administered

AccuPlex™ SARS-CoV-2 Verification Panel and Reference Material Kit are now available with full SARS-CoV-2 viral genome coverage

Based on the results, the U.S.-based trial has been stopped, including in a second cohort of patients who received a higher dose of Kevzara (800 mg)

Partnerships, products, and solutions facilitate detection, research, and vaccine development to combat the SARS-CoV-2 virus

Establishing a broad range of remotely accessible COVID-19 assays including biochemical profiling for COVID-19 drug targets

A new test being developed by Iceni Diagnostics promises a quick way to distinguish between the two diseases

Promega automated sample preparation solution added to CDC COVID-19 test protocol

The test is intended to expand availability of COVID-19 screening resources in central Ohio

New platform builds on Cytel’s East software to deliver adaptive clinical trial design and analysis